Monthly Archives: March 2009
Preemption Watch: You've Been Warned
The Supreme Court on Wednesday issued its decision in the much-watched case of Wyeth v. Levine—which many in pharma hoped would firmly establish FDA decisions as a bulwark against common-law liability suits in state courts. The decision, as you’ve no doubt heard already, went against Wyeth. Pharm Exec’s coverage is here. The opinion is here. [...]
Pfizer Acquires Generics, Branded Ophthalics
Pfizer further expanded into the generics business today, signing an agreement with Indian pharmaceutical company Aurobindo for rights to a slew of generic products. Pfizer will add to its product portfolio 39 generic solid oral dose products in the US and 20 in Europe, as well as 12 injectable products in the US and Europe. [...]
Pharma Layoffs Continue
It’s been another tough few weeks for pharma employees as four more companies handed out pink slips in an effort to trim bottom lines.
Elan cut 14 percent of its global work force last Wednesday as a part of an ongoing strategic review process. The company announced that it would postpone biologics manufacturing, redesign R&D in [...]

WeissComm Wins at PR Week